Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 5/2021

24.11.2020 | Original Article

Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies

verfasst von: Ainhoa Gutiérrez-Cobos, Sara Gómez de Frutos, Diego Domingo García, Eva Navarro Lara, Ayla Yarci Carrión, Leticia Fontán García-Rodrigo, Arturo Manuel Fraile Torres, Laura Cardeñoso Domingo

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Antibody detection is essential to establish exposure, infection, and immunity to SARS-CoV-2, as well as to perform epidemiological studies. The worldwide urge for new diagnostic tools to control the pandemic has led to a quick incorporation in clinical practice of the recently developed serological assays. However, as only few comparative studies have been published, there is a lack of data about the diagnostic accuracy of currently available assays. We evaluated the diagnostic accuracy to detect Ig G, Ig M+A, and/or IgA anti SARS-CoV-2 of 10 different assays: lateral flow card immunoassays, 4 enzyme-linked immunosorbent assay (ELISA), and 3 chemiluminescent particle immunoassays (CMIA). Using reverse transcriptase polymerase chain reaction (RT-PCR) for COVID-19 as gold standard, sensitivity, specificity, PPV, and NPV were determined. Each assay was tested in 2 groups, namely, positive control, formed by 50 sera from 50 patients with SARS-CoV-2 pneumonia with positive RT-PCR; and negative control, formed by 50 sera from 50 patients with respiratory infection non-COVID-19. Sensitivity range of the 10 assays evaluated for patients with positive COVID-19 RT-PCR was 40–77% (65–81% considering IgG plus IgM). Specificity ranged 83–100%. VPP and VPN were respectively 81–100% and 61.6–81%. Among the lateral flow immunoassays, the highest sensitivity and specificity results were found in Wondfo® SARS-CoV-2 Antibody Test. ELISA IgG and IgA from EUROIMMUN® were the most sensitive ELISA. However, poor results were obtained for isolated detection of IgG. We found similar sensitivity for IgG with SARS-CoV-2 for Architect by Abbott® and ELISA by Vircell®. Results obtained varied widely among the assays evaluated. Due to a better specificity, overall diagnostic accuracy of the assays evaluated was higher in case of positive result. On the other side, lack of antibody detection should be taken with care because of the low sensitivity described. Highest diagnostic accuracy was obtained with ELISA and CMIAs, but they last much longer.
Literatur
1.
Zurück zum Zitat Zhu N, Zhang D, Wang W et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733CrossRef Zhu N, Zhang D, Wang W et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733CrossRef
2.
Zurück zum Zitat World Health Organization (2020) Coronavirus disease 2019 (COVID-19) situation report – 78 World Health Organization (2020) Coronavirus disease 2019 (COVID-19) situation report – 78
3.
Zurück zum Zitat Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506CrossRef Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506CrossRef
8.
Zurück zum Zitat Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513CrossRef Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513CrossRef
Metadaten
Titel
Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
verfasst von
Ainhoa Gutiérrez-Cobos
Sara Gómez de Frutos
Diego Domingo García
Eva Navarro Lara
Ayla Yarci Carrión
Leticia Fontán García-Rodrigo
Arturo Manuel Fraile Torres
Laura Cardeñoso Domingo
Publikationsdatum
24.11.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 5/2021
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-04092-3

Weitere Artikel der Ausgabe 5/2021

European Journal of Clinical Microbiology & Infectious Diseases 5/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.